Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-08-16 Purchase |
2023-08-16 8:52 pm |
Taysha Gene Therapies Inc. | TSHA | Nolan Sean P. Chief Executive Officer |
444,444 | $0.9 | $400,000 | 1,536,715 (Indirect Direct) |
View |
| 2021-05-20 Purchase |
2021-05-24 08:39 am |
Taysha Gene Therapies Inc. | TSHA | Nolan Sean P. Director |
1,170 | $22.35 | $26,150 | 1,092,271 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-02 Option Award |
2025-01-03 5:38 pm |
N/A 2035-01-02 |
Taysha Gene Therapies Inc. | TSHA | Nolan Sean P. Chief Executive Officer |
892,500 | $0 | 4,506,403 (Direct) |
View |
| 2024-05-14 Option Award |
2024-05-16 5:01 pm |
N/A N/A |
Ventas Inc. | VTR | Nolan Sean P. Director |
3,648 | $47.96 | 21,252 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:41 pm |
N/A 2034-01-02 |
Taysha Gene Therapies Inc. | TSHA | Nolan Sean P. Chief Executive Officer |
1,184,688 | $0 | 3,906,091 (Direct) |
View |
| 2023-12-14 Option Award |
2023-12-18 4:46 pm |
N/A 2033-12-14 |
Taysha Gene Therapies Inc. | TSHA | Nolan Sean P. Chief Executive Officer |
466,550 | $0 | 466,550 (Direct) |
View |
| 2023-05-16 Option Award |
2023-05-18 4:48 pm |
N/A N/A |
Ventas Inc. | VTR | Nolan Sean P. Director |
3,835 | $45.63 | 17,604 (Direct) |
View |
| 2022-12-30 Option Award |
2023-01-04 4:51 pm |
N/A 2032-12-30 |
Taysha Gene Therapies Inc. | TSHA | Nolan Sean P. Chief Executive Officer |
1,106,131 | $0 | 1,106,131 (Direct) |
View |
| 2022-06-17 Option Award |
2022-06-22 4:38 pm |
N/A 2032-06-17 |
Taysha Gene Therapies Inc. | TSHA | Nolan Sean P. Director |
15,500 | $0 | 15,500 (Direct) |
View |
| 2022-04-27 Option Award |
2022-04-29 4:50 pm |
N/A N/A |
Ventas Inc. | VTR | Nolan Sean P. Director |
3,056 | $57.25 | 13,769 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-21 5:02 pm |
N/A 2031-06-17 |
Taysha Gene Therapies Inc. | TSHA | Nolan Sean P. Director |
15,500 | $0 | 15,500 (Direct) |
View |
| 2021-05-25 Option Award |
2021-05-27 5:28 pm |
N/A N/A |
Ventas Inc. | VTR | Nolan Sean P. Director |
3,158 | $0 | 10,713 (Direct) |
View |
| 2020-09-28 Conversion |
2020-09-30 4:38 pm |
N/A N/A |
Taysha Gene Therapies Inc. | TSHA | Nolan Sean P. Director |
2,092,571 | $0 | 1,091,101 (Indirect) |
View |
| 2020-09-23 Option Award |
2020-09-25 5:13 pm |
N/A 2030-09-23 |
Taysha Gene Therapies Inc. | TSHA | Nolan Sean P. Director |
31,000 | $0 | 31,000 (Direct) |
View |
Ownership |
2020-09-23 8:29 pm |
N/A N/A |
Taysha Gene Therapies Inc. | TSHA | Nolan Sean P. Director |
0 | $0 | 1,091,101 (Indirect) |
View |
| 2020-05-18 Option Award |
2020-05-20 4:53 pm |
N/A N/A |
Ventas Inc. | VTR | Nolan Sean P. Director |
5,424 | $0 | 7,555 (Direct) |
View |
| 2020-05-05 Option Award |
2020-05-07 4:25 pm |
N/A 2030-05-05 |
Neoleukin Therapeutics Inc. | NLTX | Nolan Sean P. Director |
25,000 | $0 | 25,000 (Direct) |
View |